
Gracell Biotechnologies (GRCL)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Gracell Biotechnologies (GRCL) Stock
Start investing in Gracell Biotechnologies (GRCL)
About Gracell Biotechnologies (GRCL)
Market cap | $983.25M |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 1.37M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -10.08x |
Today's range | — |
Debt / equity | — |
52 week range | $1.4 - $10.44 |
5 year debt / equity | 17.07x |
Beta (LTM) | 1.62x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 13, 2023 |
Dividend payable date | — |
Gracell Biotechnologies Stock Rating
Gracell Biotechnologies Stock News
View all



Frequently Asked Questions (FAQ)
How to buy GRCL stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in GRCL stock
Navigate to the Explore page. Then, type GRCL into the search bar. When you see GRCL stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased GRCL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Gracell Biotechnologies Stock Earnings
The value each GRCL share was expected to gain vs. the value that each GRCL share actually gained.
Gracell Biotechnologies (GRCL) reported Q3 2023 earnings per share (EPS) of -$0.10, beating estimates of -$0.20 by 50.00%. In the same quarter last year, Gracell Biotechnologies's earnings per share (EPS) was -$0.35. Gracell Biotechnologies is expected to release next earnings on 11/13/2023, with an earnings per share (EPS) estimate of $0.